Serplulimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age
NCT06354218
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Esophageal Carcinoma
Interventions
DRUG:
Serplulimab
Sponsor
The First Affiliated Hospital with Nanjing Medical University